cGxP.wire https://validator.w3.org/feed/docs/rss2.html FibroBiologics Files Patent for Cell-Based GLP-1 Production AbbVie Wins Two FDA Breakthrough Designations for Temab-A Kyverna to Present Miv-cel Data in SPS and Multiple Sclerosis Immunic Advances Vidofludimus Calcium MS Data at MSToronto2026 MimiVax Reports SurVaxM Phase 2b Glioblastoma Data Mentara Therapeutics Advances MTA-304 for Parkinson’s Lipocine Wins Health Canada Approval for TLANDO Byondis Advances ADC Platforms and BYON14156 Toward Clinic Lakewood-Amedex Reports Positive Preclinical Infection Data Bright Path Labs Wins 2026 AZBio Fast Lane Award MAIA Advances Ateganosine NSCLC Trial Enrollment Milestones CraniUS Therapeutics Expands NeuroPASS Platform With FDA Clearance Veeva Systems Accelerates Biotech Innovation With Veeva Basics SeaStar Medical Wins FDA Breakthrough Device Designation Danaher Launches AI-Powered Autonomous Lab for Life Sciences SciSparc Reports Quantum-Enabled Gene Analysis Acceleration Novartis Presents Late-Breaking MS Data at MSToronto2026 Roche Strengthens Ebola Testing Capacity in DRC Propanc Reports 90% Tumor Growth Inhibition with PRP RenovoRx Enrolls First Patient in PRISM-TAMP Trial Clearmind Submits FDA Recommendations on Neuroplastogen Therapies Artelo Biosciences to Present FABP5 Program at BIO-Europe BioCardia Advances CardiAMP HF II Trial Toward FDA Approval AIM ImmunoTech Highlights Ampligen Pancreatic Cancer Strategy Novartis Wins FDA Approval for Rhapsido in Dermographism Zealand Pharma Reports Positive Phase 2 Petrelintide Data vTv Therapeutics Wins FDA Orphan Drug Designation for HPPD Kodiak Sciences Presents Late-Stage Retina Data at AAO 2026 Kedrion Highlights Plasma Therapies at CPHI Milan 2026 Pulse Biosciences Completes NANOPULSE-AF Enrollment Seaport Therapeutics Begins Phase 2a GlyphAgo Trial Arrowhead Wins FDA STAR Pilot Entry for Plozasiran Matchpoint Therapeutics Raises $150M Series B for Pipeline Arvinas Reports ARV-102 Phase 1 Parkinson’s Data VERAXA Advances FDA-Aligned Human-Relevant Models for R&D Shionogi to Acquire IntraBio for $2B Rare Disease Growth BillionToOne Northstar Response Shows Strong Cancer Monitoring Data CHARM Therapeutics Doses First Patient in CHM-029 AML Trial REVA Medical Presents MOTIV Scaffold Results at VIVA26 QIAGEN Expands AI-Powered Bioinformatics and Drug Discovery Nurix Begins Phase 1b/2 Bexobrutideg Combination Study in CLL PulseSight Reports Early PST-611 Data in Geographic Atrophy BridgeBio Wins FDA Priority Review for Oral Infigratinib SCYNEXIS Reports Phase 1 Results for SCY-770 Saluda Medical Launches CAP24 Paddle Lead Across U.S. Kairos Pharma Reports Positive Phase 2 ENV-105 Data GigHz Study Finds 76.5% of FDA AI Devices in Radiology RougeTx Launches with $58M Series A for HHT Therapy Telix Pixclara U.S. Commercial Availability Begins Alora Pharmaceuticals Highlights RELEXXII for ADHD Care